TrialMedical oncology (Northwood, London, England)2021

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.

Peter Oppelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.